In a first for the neurotoxin market, Ipsen announced Thursday that its Dysport has hit the goals in two phase 3 trials for the prevention of both episodic and chronic migraines. While AbbVie’s market ...
Dhaka’s aesthetic medicine industry is quietly booming. It reflects changing beauty standards, social media influence, and ...
Comedian Hannah Berner is in the business of making people laugh. But now, she can't even smile. The podcaster, who cohosts ...
Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) ...
In regenerative medicine, the durable advantage rarely comes from a single product; it comes from a platform that can be pointed at more than one problem. That is the framing behind a milestone from ...
According to experts, these products really work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results